BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 22574520)

  • 21. New potent P-glycoprotein modulators with the cucurbitane scaffold and their synergistic interaction with doxorubicin on resistant cancer cells.
    Ramalhete C; Molnár J; Mulhovo S; Rosário VE; Ferreira MJ
    Bioorg Med Chem; 2009 Oct; 17(19):6942-51. PubMed ID: 19733087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversal of multidrug resistance in murine lymphoma cells by amphiphilic dihydropyridine antioxidant derivative.
    Cindric M; Cipak A; Serly J; Plotniece A; Jaganjac M; Mrakovcic L; Lovakovic T; Dedic A; Soldo I; Duburs G; Zarkovic N; Molnár J
    Anticancer Res; 2010 Oct; 30(10):4063-9. PubMed ID: 21036720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of new thioacridine derivatives on P-gp function and on mdr1 gene expression.
    Hevér A; Santelli-Rouvier C; Brouant P; el Khyari S; Molnár J; Barra Y; Barbe J
    Anticancer Res; 1998; 18(4C):3053-8. PubMed ID: 9713509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic interaction between p-glycoprotein modulators and epirubicine on resistant cancer cells.
    Duarte N; Járdánházy A; Molnár J; Hilgeroth A; Ferreira MJ
    Bioorg Med Chem; 2008 Oct; 16(20):9323-30. PubMed ID: 18824363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of chemoresistance in a cultured canine cell line by retroviral transduction of the canine multidrug resistance 1 gene.
    Matsuura S; Koto H; Ide K; Fujino Y; Setoguchi-Mukai A; Ohno K; Tsujimoto H
    Am J Vet Res; 2007 Jan; 68(1):95-100. PubMed ID: 17199425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of triterpenoids isolated from the floral spikes of Betula platyphylla var. japonica on P-glycoprotein function.
    Sekiya M; Kashiwada Y; Nabekura T; Kitagawa S; Yamagishi T; Yokozawa T; Ichiyanagi T; Ikeshiro Y; Takaishi Y
    Planta Med; 2007 Dec; 73(15):1558-62. PubMed ID: 18058609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 6,12-dihydro-1-benzopyrano[3,4-b][1,4]benzothiazin-6-ones: synthesis and mdr reversal in tumor cells.
    Shah A; Naliapara Y; Sureja D; Motohashi N; Kawase M; Miskolci C; Szabo D; Molnár J
    Anticancer Res; 1998; 18(4C):3001-4. PubMed ID: 9713499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
    Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A
    Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An in vitro and in vivo study of a novel zinc complex, zinc N-(2-hydroxyacetophenone)glycinate to overcome multidrug resistance in cancer.
    Ghosh RD; Das S; Ganguly A; Banerjee K; Chakraborty P; Sarkar A; Chatterjee M; Nanda A; Pradhan K; Choudhuri SK
    Dalton Trans; 2011 Nov; 40(41):10873-84. PubMed ID: 21717020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumour-specific cytotoxicity and MDR-reversal activity of dihydropyridines.
    Engi H; Sakagami H; Kawase M; Parecha A; Manvar D; Kothari H; Adlakha P; Shah A; Motohashi N; Ocsovszki I; Molnár J
    In Vivo; 2006; 20(5):637-43. PubMed ID: 17091771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
    Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N,N-bis(cyclohexanol)amine aryl esters inhibit P-glycoprotein as transport substrates.
    Neri A; Frosini M; Valoti M; Cacace MG; Teodori E; Sgaragli G
    Biochem Pharmacol; 2011 Dec; 82(12):1822-31. PubMed ID: 21920352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of pyridine-2-ones as novel class of multidrug resistance (MDR) modulators: first structure-activity relationships.
    Krawczyk S; Otto M; Otto A; Coburger C; Krug M; Seifert M; Tell V; Molnár J; Hilgeroth A
    Bioorg Med Chem; 2011 Nov; 19(21):6309-15. PubMed ID: 21964185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Euphorbia factor L1 reverses ABCB1-mediated multidrug resistance involving interaction with ABCB1 independent of ABCB1 downregualtion.
    Zhang JY; Mi YJ; Chen SP; Wang F; Liang YJ; Zheng LS; Shi CJ; Tao LY; Chen LM; Chen HB; Fu LW
    J Cell Biochem; 2011 Apr; 112(4):1076-83. PubMed ID: 21308736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 3'-O, 4'-O-aromatic acyl substituted 7,8-pyranocoumarins: a new class of P-glycoprotein modulators.
    Shen X; Chen G; Zhu G; Cai J; Wang L; Hu Y; Fong WF
    J Pharm Pharmacol; 2012 Jan; 64(1):90-100. PubMed ID: 22150676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.
    Li X; Sun B; Zhu CJ; Yuan HQ; Shi YQ; Gao J; Li SJ; Lou HX
    Toxicol In Vitro; 2009 Feb; 23(1):29-36. PubMed ID: 18938236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flavonoid dimers as bivalent modulators for P-glycoprotein-based multidrug resistance: synthetic apigenin homodimers linked with defined-length poly(ethylene glycol) spacers increase drug retention and enhance chemosensitivity in resistant cancer cells.
    Chan KF; Zhao Y; Burkett BA; Wong IL; Chow LM; Chan TH
    J Med Chem; 2006 Nov; 49(23):6742-59. PubMed ID: 17154505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alteration of substrate specificity by mutations at the His61 position in predicted transmembrane domain 1 of human MDR1/P-glycoprotein.
    Taguchi Y; Kino K; Morishima M; Komano T; Kane SE; Ueda K
    Biochemistry; 1997 Jul; 36(29):8883-9. PubMed ID: 9220975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trimethoxybenzanilide-based P-glycoprotein modulators: an interesting case of lipophilicity tuning by intramolecular hydrogen bonding.
    Tardia P; Stefanachi A; Niso M; Stolfa DA; Mangiatordi GF; Alberga D; Nicolotti O; Lattanzi G; Carotti A; Leonetti F; Perrone R; Berardi F; Azzariti A; Colabufo NA; Cellamare S
    J Med Chem; 2014 Aug; 57(15):6403-18. PubMed ID: 25093931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of 9,10-Dihydroacridines as Novel Class of ABCB1 Inhibitors.
    Hilgeroth A; Hemmer M; Neuber S; Molnár J; Lage H
    Med Chem; 2015; 11(4):329-35. PubMed ID: 25391533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.